浙江同源康医药股份有限公司（股票代码：02410，简称同源康医药-B）于2026年4月8日披露截至2026年3月31日的股份变动月报表。公告显示，公司报告期内完成将4,608,000股非上市股份转换为等量H股，但已发行股份总数保持不变。
报告期末，公司法定（注册）股本总额为380,065,818股，较上月底并无增减变化。其中，H股数量从上月底的375,457,818股增至380,065,818股，非上市股份则相应降至0股。整个报告期内，公司未发生新的发行、购回或注销股份，也无库存股份以及股份期权或股权激励计划的变动。
截至3月31日，公司股本总数依旧为380,065,818股，股权转换未对股本规模造成影响。公司确认已遵守香港联交所《上市规则》等相关法规。本次月报表由执行董事、董事长兼总裁吴豫生签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.